Skip to main content
Equibles

Jennifer Fulk

CFO

Kura Oncology, Inc. (KURA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jennifer Fulk

Jennifer Fulk is recorded as CFO at Kura Oncology, Inc. (KURA). Kura Oncology, Inc. reported in an 8-K filed September 8, 2026 that Jennifer Fulk was appointed Chief Financial Officer, principal financial officer and principal accounting officer, effective September 8, 2026. Jennifer Fulk has spoken on 1 investor event across 1 company, most recently for Kura Oncology, Inc. on September 16, 2026.

“Effective as of September 8, 2026, the Board of Directors (the "Board") of Kura Oncology, Inc. (the "Company") appointed Jennifer Fulk as the Company's Chief Financial Officer, principal financial officer (replacing Troy E. Wilson, Ph.D., J.D. solely with respect to such role) and principal accounting officer (replacing Thomas Doyle solely with respect to such role).”
Kura Oncology, Inc. Form 8-K, filed September 8, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Kura Oncology, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.